S-Ventures PLC – Arrangement of Loan Facility

RNS Number : 4189S
S-Ventures PLC
06 November 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

S-Ventures PLC

(“S-Ventures” or the “Group”)

Arrangement of Loan Facility

S-Ventures (AQSE: SVEN), the company investing in brands across the natural, wellness and food-tech categories, is pleased to announce that the Group has secured a bridging loan facility of £1m, which is predominantly for short-term working capital purposes and will be repayable in six months. The facility has been secured through a Middle Eastern family office and enables S-Ventures to secure working capital as it works through its fundraise plans and process. The facility is in two tranches of £500,000. The first tranche has been made available and the second tranche will be available on 6 November 2023. The facility bears an interest rate of 2 per cent. per month and has been secured by a debenture, and is also supported by a personal guarantee from S-Venture’s CEO, Scott Livingston.

We expect to update the market on the fundraise announced on 18th October in due course.

 

For further information, please contact:

 

S-Ventures plc

Scott Livingston (Chief Executive Officer)

+44 (0) 1932 400 224

Stephen Argent (Chief Financial Officer)

 

 

VSA Capital, AQSE Corporate Adviser and Broker:

Andrew Raca

Matt Harker

 

+44 (0) 20 3005 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END